emerging glp-1 gip obesity treatments 2025 Pipeline Update: May - Prime Therapeutics GLP-1-based therapies for type 2

Sardu C, Santamaria M, Funaro S, Sacra C, Barbieri M, Paolisso P, Marfella R, Paolisso G, Rizzo MR

Clinical trial data shows oral Wegovy delivers an average 15% body weight loss over 68 weeks, compared to roughly 17% with injectable semaglutide at the highest dose

Participants take supplement capsules in the morning, a shake at lunch and change their Thrive Patch in the afternoon

Alexandra Sowa, MD, author of the upcoming book The Ozempic Revolution , agrees.This should not be used as a drug to get even skinnier, she says

Not So Much

Free of: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, soybeans and yeast